Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

J. Peter Oettgen, M.D.

Co-Author

This page shows the publications co-authored by J. Oettgen and Towia Libermann.
Connection Strength

2.512
  1. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem. 2000 Jan 14; 275(2):1216-25.
    View in: PubMed
    Score: 0.219
  2. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J Biol Chem. 1999 Oct 08; 274(41):29439-52.
    View in: PubMed
    Score: 0.215
  3. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Genomics. 1999 Feb 01; 55(3):358-62.
    View in: PubMed
    Score: 0.205
  4. The Novel Epithelial-Specific Ets Transcription Factor Gene ESX Maps to Human Chromosome 1q32.1 Genomics. 1997 Oct 15; 445(2):456-7.
    View in: PubMed
    Score: 0.188
  5. The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1. Genomics. 1997 Oct 15; 45(2):456-7.
    View in: PubMed
    Score: 0.188
  6. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol. 1997 Aug; 17(8):4419-33.
    View in: PubMed
    Score: 0.185
  7. Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1. Mol Cell Biol. 1996 Sep; 16(9):5091-106.
    View in: PubMed
    Score: 0.174
  8. Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics. 2010 May 28; 11:342.
    View in: PubMed
    Score: 0.112
  9. Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144) during endothelial differentiation. BMC Genomics. 2008 May 22; 9:240.
    View in: PubMed
    Score: 0.098
  10. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J. 2005 Apr; 272(7):1676-87.
    View in: PubMed
    Score: 0.079
  11. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem. 2004 Jun 11; 279(24):25241-50.
    View in: PubMed
    Score: 0.073
  12. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene. J Biol Chem. 2004 May 07; 279(19):19512-22.
    View in: PubMed
    Score: 0.073
  13. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem. 2004 Mar 26; 279(13):12794-803.
    View in: PubMed
    Score: 0.072
  14. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 2003 May; 48(5):1249-60.
    View in: PubMed
    Score: 0.069
  15. Opposing functions of the Ets factors NERF and ELF-1 during chicken blood vessel development. Arterioscler Thromb Vasc Biol. 2002 Jul 01; 22(7):1106-12.
    View in: PubMed
    Score: 0.065
  16. Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res. 2001 Feb 02; 88(2):237-44.
    View in: PubMed
    Score: 0.059
  17. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6. J Biol Chem. 2001 Mar 23; 276(12):9421-36.
    View in: PubMed
    Score: 0.058
  18. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J Biol Chem. 2001 Feb 02; 276(5):3302-9.
    View in: PubMed
    Score: 0.058
  19. ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J Biol Chem. 2000 Jan 28; 275(4):2986-98.
    View in: PubMed
    Score: 0.055
  20. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ Res. 1999 May 28; 84(10):1177-85.
    View in: PubMed
    Score: 0.052
  21. ELF-1 interacts with and transactivates the IgH enhancer pi site. J Biol Chem. 1996 Oct 18; 271(42):26007-12.
    View in: PubMed
    Score: 0.044
  22. Interleukin-6 Gene Expression by Prostaglandins and Cyclic AMP Mediated by Multiple Regulatory Elements. Am J Ther. 1995 Sep; 2(9):660-665.
    View in: PubMed
    Score: 0.040
  23. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol. 1994 Jul; 14(7):4443-54.
    View in: PubMed
    Score: 0.037
  24. ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development. Mol Cell Biol. 1994 May; 14(5):3292-309.
    View in: PubMed
    Score: 0.037
  25. ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol. 2008 May; 215(2):562-73.
    View in: PubMed
    Score: 0.024
  26. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem. 2005 Nov 18; 280(46):38544-55.
    View in: PubMed
    Score: 0.020
  27. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci U S A. 1998 Feb 03; 95(3):1213-7.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.